Achillea Apoptosis Cervical cancer LIN28B p53

Journal

Reports of biochemistry & molecular biology
ISSN: 2322-3480
Titre abrégé: Rep Biochem Mol Biol
Pays: Iran
ID NLM: 101637937

Informations de publication

Date de publication:
Oct 2019
Historique:
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 11 4 2020
Statut: ppublish

Résumé

Inappropriate activation of the proto-oncogene LIN28B and inactivation of the p53 tumor suppressor, have been shown to have a critical role in tumorigenesis. Previous research has shown therapeutic potential for the use of herbal plants as an alternative strategy for cancer treatment. The cytotoxic activity of Treatment with Our findings confirmed the pro-apoptotic function of

Sections du résumé

BACKGROUND BACKGROUND
Inappropriate activation of the proto-oncogene LIN28B and inactivation of the p53 tumor suppressor, have been shown to have a critical role in tumorigenesis. Previous research has shown therapeutic potential for the use of herbal plants as an alternative strategy for cancer treatment.
METHODS METHODS
The cytotoxic activity of
RESULTS RESULTS
Treatment with
CONCLUSION CONCLUSIONS
Our findings confirmed the pro-apoptotic function of

Identifiants

pubmed: 32274404
pmc: PMC7103081

Types de publication

Journal Article

Langues

eng

Pagination

318-325

Références

Breast Cancer (Auckl). 2017 Feb 23;11:1178223417690178
pubmed: 28469435
Int J Oncol. 2014 Dec;45(6):2421-9
pubmed: 25201220
Molecules. 2009 Feb 13;14(2):738-54
pubmed: 19223822
Hum Vaccin. 2009 Oct;5(10):705-19
pubmed: 19684472
Pak J Pharm Sci. 2016 Nov;29(6 Suppl):2397-2403
pubmed: 28167484
Oncogene. 2003 Dec 8;22(56):9030-40
pubmed: 14663481
Nat Rev Cancer. 2005 Nov;5(11):876-85
pubmed: 16239906
Int J Mol Sci. 2013 Aug 09;14(8):16532-53
pubmed: 23939427
Apoptosis. 2017 Mar;22(3):475-477
pubmed: 28102458
Wiley Interdiscip Rev Comput Mol Sci. 2016 Mar;6(2):147-172
pubmed: 27066112
Biologics. 2008 Mar;2(1):97-105
pubmed: 19707432
Oncol Rep. 2015 Feb;33(2):997-1003
pubmed: 25515921
Nat Genet. 2009 Jul;41(7):843-8
pubmed: 19483683
Nutr Cancer. 2010;62(1):1-20
pubmed: 20043255
Cell. 2009 Nov 13;139(4):693-706
pubmed: 19878981
Biomed Rep. 2017 Sep;7(3):251-256
pubmed: 28811896
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
Front Genet. 2017 Mar 28;8:31
pubmed: 28400788
Curr Opin Mol Ther. 2010 Apr;12(2):147-57
pubmed: 20373258
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
Curr Oncol. 2010 Feb;17(1):70-80
pubmed: 20179807
Oncogene. 2015 Feb 26;34(9):1094-104
pubmed: 24662829
Pharmacogn Mag. 2015 Oct;11(Suppl 2):S308-15
pubmed: 26664020
Transl Pediatr. 2015 Jan;4(1):4-11
pubmed: 26835354
Tumour Biol. 2014 Mar;35(3):2279-84
pubmed: 24272199
PLoS One. 2012;7(7):e40008
pubmed: 22808086
Hepatology. 2010 Nov;52(5):1731-40
pubmed: 20827722

Auteurs

Mehdi Rezai (M)

Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.

Ramin Saravani (R)

Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.

Saman Sargazi (S)

Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.

Mahdiyeh Moudi (M)

Genetics of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

Mahdieh Jafari Shahroudi (M)

Cellular and Molecular Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.

Roya Saravani (R)

Department of Chemistry, Iran University of Science and Technology; Tehran, Iran.

Classifications MeSH